Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Nishimura H, Yerkes E, Hohenfellner K, Miyazaki Y, Ma J, Hunley TE, Yoshida H, Ichiki T, Threadgill D, Phillips JA, Hogan BM, Fogo A, Brock JW, Inagami T, Ichikawa I (1999) Mol Cell 3: 1-10 ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers. Kamat AM, Hegarty PK, Gee JR, Clark PE, Svatek RS, Hegarty N, Shariat SF, Xylinas E, Schmitz-Dräger BJ, Lotan Y, Jenkins LC, Droller M, van Rhijn BW, Karakiewicz PI, International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012 (2013) Eur Urol 63: 4-15 Racial variation in the quality of surgical care for bladder cancer. Barocas DA, Alvarez J, Koyama T, Anderson CB, Gray DT, Fowke JH, You C, Chang SS, Cookson MS, Smith JA, Penson DF (2014) Cancer 120: 1018-25 Variation in the intensity of hematuria evaluation: a target for primary care quality improvement. Friedlander DF, Resnick MJ, You C, Bassett J, Yarlagadda V, Penson DF, Barocas DA (2014) Am J Med 127: 633-640.e11 Developments and controversies in the management of noninvasive bladder cancer. Bassett JC, Eifler JB, Resnick MJ, Clark PE (2014) Curr Opin Oncol 26: 299-304 Incontinence rates after midurethral sling revision for vaginal exposure or pain. Jambusaria LH, Heft J, Reynolds WS, Dmochowski R, Biller DH (2016) Am J Obstet Gynecol 215: 764.e1-764.e5 National Trends in Followup Imaging after Pyeloplasty in Children in the United States. Hsi RS, Holt SK, Gore JL, Lendvay TS, Harper JD (2015) J Urol 194: 777-82 Obturator foramen dissection for excision of symptomatic transobturator mesh. Reynolds WS, Kit LC, Kaufman MR, Karram M, Bales GT, Dmochowski RR (2012) J Urol 187: 1680-4 National Trends in Secondary Procedures Following Pediatric Pyeloplasty. Dy GW, Hsi RS, Holt SK, Lendvay TS, Gore JL, Harper JD (2016) J Urol 195: 1209-14 Bullying and lower urinary tract symptoms: why the pediatric urologist should care about school bullying. Ching CB, Lee H, Mason MD, Clayton DB, Thomas JC, Pope JC, Adams MC, Brock JW, Tanaka ST (2015) J Urol 193: 650-4 Patterns and predictors of urodynamics use in the United States. Reynolds WS, Dmochowski RR, Lai J, Saigal C, Penson DF, Urologic Diseases in America Project (2013) J Urol 189: 1791-6 The aging pediatric urology patient: obstacles and opportunities in transition care. Tanaka ST, Kaufman MR, Brock JW (2012) J Urol 187: 1159-60 Transverse myelitis in children: long-term urological outcomes. Tanaka ST, Stone AR, Kurzrock EA (2006) J Urol 175: 1865-8; discussion 1868 Orchiopexy for intra-abdominal testes: factors predicting success. Stec AA, Tanaka ST, Adams MC, Pope JC, Thomas JC, Brock JW (2009) J Urol 182: 1917-20 Short stay pyeloplasty: variables affecting pain and length of stay. Chamie K, Tanaka ST, Hu B, Kurzrock EA (2008) J Urol 179: 1549-52 Training residents in hypospadias repair: variations of involvement. DeLair SM, Tanaka ST, Yap SA, Kurzrock EA (2008) J Urol 179: 1102-6 Assessing retroperitoneal lymphadenectomy experience in United States urological residency programs. Lowrance WT, Cookson MS, Clark PE, Smith JA, Chang SS (2007) J Urol 178: 500-3; discussion 503 Postoperative Opiate Use in Urological Patients: A Quality Improvement Study Aimed at Improving Opiate Disposal Practices. Cabo J, Hsi RS, Scarpato KR (2019) J Urol 201: 371-376 Trends in followup imaging after adult pyeloplasty. Hsi RS, Holt SK, Gore JL, Harper JD (2014) J Urol 191: 1357-62 Pay for performance: rationale and potential implications for urology. Gonzalez CM, Penson D, Kosiak B, Dupree J, Clemens JQ (2007) J Urol 178: 402-8 Composite thin film and electrospun biomaterials for urologic tissue reconstruction. Kundu AK, Gelman J, Tyson DR (2011) Biotechnol Bioeng 108: 207-15 Outcomes session. Penson DF, Barocas DA, Fleshner N, Sanda MG, Greenfield S (2012) Urol Oncol 30: 952-5 Systemic therapy and the urologic oncologist: a unique opportunity for the specialty to provide comprehensive care that ultimately benefits the patient. Penson DF, Lange PH (2012) Urol Oncol 30: S2-4 A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions? Kurpad R, Kim W, Rathmell WK, Godley P, Whang Y, Fielding J, Smith L, Pettiford A, Schultz H, Nielsen M, Wallen EM, Pruthi RS (2011) Urol Oncol 29: 378-82 Comprehensive handbook for developing a bladder cancer cystectomy database. Lotan Y, Amiel G, Boorjian SA, Clark PE, Droller M, Gingrich JR, Guzzo TJ, Inman BA, Kamat AM, Karsh L, Nielsen ME, Smith ND, Shariat SF, Svatek RS, Taylor JM, Bladder Cancer Think Tank, Bladder Cancer Advocacy Network (2013) Urol Oncol 31: 812-26 The Patient Protection and Affordable Care Act: the impact on urologic cancer care. Keegan KA, Penson DF (2013) Urol Oncol 31: 980-4 Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database--UNC GOLD. Gallagher SA, Smith AB, Matthews JE, Potter CW, Woods ME, Raynor M, Wallen EM, Rathmell WK, Whang YE, Kim WY, Godley PA, Chen RC, Wang A, You C, Barocas DA, Pruthi RS, Nielsen ME, Milowsky MI (2014) Urol Oncol 32: 32.e1-9 ACE I/D gene polymorphism predicts renal damage in congenital uropathies. Hohenfellner K, Hunley TE, Brezinska R, Brodhag P, Shyr Y, Brenner W, Habermehl P, Kon V (1999) Pediatr Nephrol 13: 514-8 Publication misrepresentation among urology residency applicants. Hsi RS, Hotaling JM, Moore TN, Joyner BD (2013) World J Urol 31: 697-702 Cost-effective management of pelvic fracture urethral injuries. Johnsen NV, Penson DF, Reynolds WS, Milam DF, Dmochowski RR, Kaufman MR (2017) World J Urol 35: 1617-1623 Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity. Padmanabhan P, Scarpero HM, Milam DF, Dmochowski RR, Penson DF (2011) World J Urol 29: 51-7 Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions. Ramsey SD, Zeliadt SB, Fedorenko CR, Blough DK, Moinpour CM, Hall IJ, Smith JL, Ekwueme DU, Fairweather ME, Thompson IM, Keane TE, Penson DF (2011) World J Urol 29: 3-9 Immediate effects of the initial FDA notification on the use of surgical mesh for pelvic organ prolapse surgery in medicare beneficiaries. Reynolds WS, Gold KP, Ni S, Kaufman MR, Dmochowski RR, Penson DF (2013) Neurourol Urodyn 32: 330-5 The impact of frailty on treatment for overactive bladder in older adults. Suskind AM, Kowalik C, Quanstrom K, Boscardin J, Zhao S, Reynolds WS, Mishra K, Finlayson E (2019) Neurourol Urodyn 38: 1915-1923 Pediatric urologic conditions, including urinary infections. Tanaka ST, Brock JW (2011) Med Clin North Am 95: 1-13 Evaluation of the axonics modulation technologies sacral neuromodulation system for the treatment of urinary and fecal dysfunction. Cohn JA, Kowalik CG, Kaufman MR, Reynolds WS, Milam DF, Dmochowski RR (2017) Expert Rev Med Devices 14: 3-14 Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer. Ritch CR, You C, May AT, Herrell SD, Clark PE, Penson DF, Chang SS, Cookson MS, Smith JA, Barocas DA (2014) Urology 83: 1309-15
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.